IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 20 filers reported holding IO BIOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,614,401 | -27.9% | 1,854,185 | 0.0% | 0.00% | – |
| Q2 2023 | $3,624,932 | +4.3% | 1,854,185 | 0.0% | 0.00% | – |
| Q1 2023 | $3,476,597 | -18.5% | 1,854,185 | 0.0% | 0.00% | – |
| Q4 2022 | $4,264,625 | +15694.9% | 1,854,185 | +18441.8% | 0.00% | – |
| Q3 2022 | $27,000 | -42.6% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $47,000 | -11.3% | 10,000 | 0.0% | 0.00% | – |
| Q1 2022 | $53,000 | -17.2% | 10,000 | 0.0% | 0.00% | – |
| Q4 2021 | $64,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,120,437 | $5,938,000 | 1.50% |
| Vivo Capital, LLC | 3,015,545 | $15,982,000 | 1.10% |
| Novo Holdings A/S | 3,277,932 | $17,373,000 | 0.92% |
| Soleus Capital Management, L.P. | 672,734 | $3,565,000 | 0.46% |
| PFM Health Sciences, LP | 1,362,144 | $6,649,000 | 0.25% |
| RA Capital Management | 1,857,755 | $9,846,000 | 0.22% |
| Avoro Capital Advisors LLC | 2,055,883 | $9,580,000 | 0.18% |
| Ergoteles LLC | 11,126 | $59,000 | 0.00% |
| Capital World Investors | 1,235,000 | $6,546,000 | 0.00% |
| VANGUARD GROUP INC | 62,234 | $330,000 | 0.00% |